Literature DB >> 8538796

Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2.

M J Eck1, S Pluskey, T Trüb, S C Harrison, S E Shoelson.   

Abstract

The domain organization of many signalling proteins facilitates a segregation of binding, catalytic and regulatory functions. The mammalian SH2 domain protein tyrosine phosphatases (PTPs) contain tandem SH2 domains and a single carboxy-terminal catalytic domain. SH-PTP1 (PTP1C, HCP) and SH-PTP2 (Syp, PTP2C, PTP1D) function downstream from tyrosine kinase-linked insulin, growth factor, cytokine and antigen receptors. As well as directing subcellular localization by binding to receptors and their substrates, the two SH2 domains of these PTPs function together to regulate catalysis. Here we report the structure of the tandem SH2 domains of SH-PTP2 in complex with monophosphopeptides. A fixed relative orientation of the two domains, stabilized by a disulphide bond and a small hydrophobic patch within the interface, separates the peptide binding sites by approximately 40 A. The defined orientation of the SH2 domains in the structure, and data showing that peptide orientation and spacing between binding sites is critical for enzymatic activation, suggest that spatial constraints are important in this multidomain protein-protein interaction.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8538796     DOI: 10.1038/379277a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  50 in total

1.  Noncanonical tandem SH2 enables interaction of elongation factor Spt6 with RNA polymerase II.

Authors:  Marie-Laure Diebold; Erin Loeliger; Michael Koch; Fred Winston; Jean Cavarelli; Christophe Romier
Journal:  J Biol Chem       Date:  2010-10-06       Impact factor: 5.157

2.  Mechanism of phosphorylation-induced activation of phospholipase C-gamma isozymes.

Authors:  Aurelie Gresset; Stephanie N Hicks; T Kendall Harden; John Sondek
Journal:  J Biol Chem       Date:  2010-08-31       Impact factor: 5.157

3.  A tandem SH2 domain in transcription elongation factor Spt6 binds the phosphorylated RNA polymerase II C-terminal repeat domain (CTD).

Authors:  Mai Sun; Laurent Larivière; Stefan Dengl; Andreas Mayer; Patrick Cramer
Journal:  J Biol Chem       Date:  2010-10-06       Impact factor: 5.157

Review 4.  Targeting protein tyrosine phosphatases for anticancer drug discovery.

Authors:  Latanya M Scott; Harshani R Lawrence; Saïd M Sebti; Nicholas J Lawrence; Jie Wu
Journal:  Curr Pharm Des       Date:  2010-06       Impact factor: 3.116

5.  Kinase activation through dimerization by human SH2-B.

Authors:  Masahiro Nishi; Eric D Werner; Byung-Chul Oh; J Daniel Frantz; Sirano Dhe-Paganon; Lone Hansen; Jongsoon Lee; Steven E Shoelson
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

6.  Structure-based kinetic models of modular signaling protein function: focus on Shp2.

Authors:  Dipak Barua; James R Faeder; Jason M Haugh
Journal:  Biophys J       Date:  2007-01-05       Impact factor: 4.033

7.  Computational models of tandem SRC homology 2 domain interactions and application to phosphoinositide 3-kinase.

Authors:  Dipak Barua; James R Faeder; Jason M Haugh
Journal:  J Biol Chem       Date:  2008-01-20       Impact factor: 5.157

8.  Identification of cryptotanshinone as an inhibitor of oncogenic protein tyrosine phosphatase SHP2 (PTPN11).

Authors:  Wei Liu; Bing Yu; Gang Xu; Wei-Ren Xu; Mignon L Loh; Li-Da Tang; Cheng-Kui Qu
Journal:  J Med Chem       Date:  2013-09-04       Impact factor: 7.446

9.  ErbB3 (HER3) interaction with the p85 regulatory subunit of phosphoinositide 3-kinase.

Authors:  N J Hellyer; K Cheng; J G Koland
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

10.  Small Molecule Inhibitor that Stabilizes the Autoinhibited Conformation of the Oncogenic Tyrosine Phosphatase SHP2.

Authors:  Xiaoqin Wu; Gang Xu; Xiaobo Li; Weiren Xu; Qianjin Li; Wei Liu; Karen A Kirby; Mignon L Loh; Jun Li; Stefan G Sarafianos; Cheng-Kui Qu
Journal:  J Med Chem       Date:  2018-12-05       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.